Pharmaceutical Sciences Department, University of Illinois College of Pharmacy, Rockford, Illinois.
Departments of Immunology and Biochemistry, University of Washington, Seattle, Washington.
Curr Protoc. 2021 Oct;1(10):e250. doi: 10.1002/cpz1.250.
Topoisomerases are enzymes that play essential roles in DNA replication, transcription, chromosome segregation, and recombination. All cells have two major forms of DNA topoisomerases: type I enzymes, which make single-stranded cuts in DNA, and type II enzymes, which cut and decatenate double-stranded DNA. DNA topoisomerases are important targets of approved and experimental anti-cancer agents. Provided in this article are protocols to assess activities of topoisomerases and their inhibitors. Included are an assay for topoisomerase I activity based on relaxation of supercoiled DNA; an assay for topoisomerase II based on the decatenation of double-stranded DNA; and approaches for enriching and quantifying DNA-protein covalent complexes formed as obligatory intermediates in the reactions of type I and II topoisomerases with DNA; and assays for measuring DNA cleavage in vitro. Topoisomerases are not the only proteins that form covalent adducts with DNA in living cells, and the approaches described here are likely to find use in characterizing other protein-DNA adducts and exploring their utility as targets for therapy. © 2021 Wiley Periodicals LLC. Basic Protocol 1: Assay of topoisomerase I activity Basic Protocol 2: Assay of topoisomerase II activity Basic Protocol 3: In vivo determination of topoisomerase covalent complexes using the in vivo complex of enzyme (ICE) assay Support Protocol 1: Preparation of mouse tissue for determination of topoisomerase covalent complexes using the ICE assay Support Protocol 2: Using recombinant topoisomerase standard for absolute quantification of cellular TOP2CC Basic Protocol 4: Quantification of topoisomerase-DNA covalent complexes by RADAR/ELISA: The rapid approach to DNA adduct recovery (RADAR) combined with the enzyme-linked immunosorbent assay (ELISA) Basic Protocol 5: Analysis of protein-DNA covalent complexes by RADAR/Western Support Protocol 3: Adduct-Seq to characterize adducted DNA Support Protocol 4: Nuclear fractionation and RNase treatment to reduce sample complexity Basic Protocol 6: Determination of DNA cleavage by purified topoisomerase I Basic Protocol 7: Determination of inhibitor effects on DNA cleavage by topoisomerase II using a plasmid linearization assay Alternate Protocol: Gel electrophoresis determination of topoisomerase II cleavage.
拓扑异构酶在 DNA 复制、转录、染色体分离和重组中发挥着重要作用。所有细胞都有两种主要形式的 DNA 拓扑异构酶:Ⅰ型酶,可在 DNA 上形成单链切口,Ⅱ型酶,可切割并解链双链 DNA。DNA 拓扑异构酶是已批准和实验性抗癌药物的重要靶点。本文提供了评估拓扑异构酶及其抑制剂活性的方案。其中包括一种基于超螺旋 DNA 松弛的拓扑异构酶 I 活性测定法;一种基于双链 DNA 解链的拓扑异构酶 II 测定法;以及用于富集和定量作为 I 型和 II 型拓扑异构酶与 DNA 反应中必需中间体形成的 DNA-蛋白共价复合物的方法;以及体外 DNA 切割测定法。拓扑异构酶并不是唯一在活细胞中与 DNA 形成共价加合物的蛋白质,这里描述的方法可能会被用于表征其他蛋白-DNA 加合物,并探索它们作为治疗靶点的用途。© 2021 威利父子公司。基本方案 1:拓扑异构酶 I 活性测定基本方案 2:拓扑异构酶 II 活性测定基本方案 3:使用体内酶复合物(ICE)测定法在体内测定拓扑异构酶共价复合物支持方案 1:使用 ICE 测定法测定组织中拓扑异构酶共价复合物的小鼠组织准备支持方案 2:使用重组拓扑异构酶标准进行细胞内 TOP2CC 的绝对定量基本方案 4:通过 RADAR/ELISA 定量拓扑异构酶-DNA 共价复合物:RADAR(快速 DNA 加合物回收)与酶联免疫吸附测定法(ELISA)的结合基本方案 5:RADAR/Western 分析蛋白-DNA 共价复合物支持方案 3:Adduct-Seq 用于表征加合物 DNA支持方案 4:核分馏和 RNase 处理以降低样品复杂性基本方案 6:通过纯化的拓扑异构酶 I 测定 DNA 切割基本方案 7:使用质粒线性化测定法测定拓扑异构酶 II 抑制剂对 DNA 切割的影响备选方案:凝胶电泳测定拓扑异构酶 II 切割。